Search results for “Chronic cough” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 337 patents, we discovered top 137 key players by total patent application. Afferent Pharmaceuticals, Inc., NeRRe Therapeutics Ltd., Axalbion SA are dominant in this area. They take 19.88% of the total patent filing.
Afferent Pharmaceuticals, Inc.
California, United States
Patent: 33
NeRRe Therapeutics Ltd.
Herefordshire, United Kingdom
Patent: 17
Axalbion SA
Vaud, Switzerland
Patent: 17
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
United Kingdom
Patent: 17
Bayer AG
Nordrhein-Westfalen, Germany
Patent: 16
Shionogi & Co., Ltd.
Osaka-fu, Japan
Patent: 16
Bayer Pharma AG
Berlin, Germany
Patent: 16
Ono Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 11
Trevi Therapeutics, Inc.
Connecticut, United States
Patent: 11
Aerin Medical, Inc.
California, United States
Patent: 11
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 208 patents applied in the last 5 years. We discover 80 most active companies in this area. The fast-growing Axalbion SA, Bayer AG, Shionogi & Co., Ltd. take 23.56% of patent filing during this period.
Axalbion SA
Vaud, Switzerland
Patent: 17
Bayer AG
Nordrhein-Westfalen, Germany
Patent: 16
Shionogi & Co., Ltd.
Osaka-fu, Japan
Patent: 16
Bayer Pharma AG
Berlin, Germany
Patent: 16
Neomed Institute
Quebec, Canada
Patent: 12
Trevi Therapeutics, Inc.
Connecticut, United States
Patent: 11
BELLUS Health Cough, Inc.
Canada
Patent: 10
GBS Global Biopharma, Inc.
Ontario, Canada
Patent: 6
Passy-Muir, Inc.
Texas, United States
Patent: 5
China Pharmaceutical Research & Development Center Co., Ltd.
China
Patent: 5
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 208 patents in last 5 years, we discover 74 new entrants. Axalbion SA, Bayer AG, Shionogi & Co., Ltd. are the most active new entrants in this area.
Axalbion SA
Vaud, Switzerland
Patent: 17
Bayer AG
Nordrhein-Westfalen, Germany
Patent: 16
Shionogi & Co., Ltd.
Osaka-fu, Japan
Patent: 16
Bayer Pharma AG
Berlin, Germany
Patent: 16
Neomed Institute
Quebec, Canada
Patent: 12
Trevi Therapeutics, Inc.
Connecticut, United States
Patent: 11
BELLUS Health Cough, Inc.
Canada
Patent: 10
GBS Global Biopharma, Inc.
Ontario, Canada
Patent: 6
Passy-Muir, Inc.
Texas, United States
Patent: 5
China Pharmaceutical Research & Development Center Co., Ltd.
China
Patent: 5
Research Institutions
Order by:
Innovation Intensity
With the analysis among 71 patents, we discovered top 21 universities and scientific research institutions by total patent application. The Rockefeller University, Sun Yat-Sen University, Zhejiang University are dominant in this area. They take 38.03% of the total patent filing.
The Rockefeller University
New York, United States
Patent: 5
Sun Yat-Sen University
Guangdong Sheng, China
Patent: 4
Zhejiang University
Zhejiang Sheng, China
Patent: 4
Kumamoto University
Kumamoto-ken, Japan
Patent: 4
Council of Scientific & Industrial Research
Delhi, India
Patent: 2
McMaster University
Ontario, Canada
Patent: 2
Fourth Military Medical University
Hunan Sheng, China
Patent: 2
Chengdu University of Traditional Chinese Medicine
Sichuan Sheng, China
Patent: 2
Shanghai Jiao Tong University
Shanghai Shi, China
Patent: 1
Emory University
Georgia, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: